Selective Disruption of Insulin-like Growth Factor-1 (IGF-1) Signaling via Phosphoinositide-dependent Kinase-1 Prevents the Protective Effect of IGF-1 on Human Cancer Cell Death
Open Access
- 26 February 2010
- journal article
- research article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 285 (9), 6563-6572
- https://doi.org/10.1074/jbc.m109.097410
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- Relationships of Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor Expression to Clinical Outcomes in Patients with Colorectal CancerOncology, 2008
- The life of a cell: apoptosis regulation by the PI3K/PKB pathwayBiochemical Journal, 2008
- Mechanisms of resistance to ErbB-targeted cancer therapeuticsJCI Insight, 2008
- Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteinsJCI Insight, 2008
- Advances in Male ContraceptionEndocrine Reviews, 2008
- An immunohistochemical perspective of PPARβ and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumoursBritish Journal of Cancer, 2008
- Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignanciesDrug Resistance Updates, 2007
- Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumorsCancer Chemotherapy and Pharmacology, 2007
- Phase I Trial of the Cyclin-Dependent Kinase Inhibitor and Protein Kinase C Inhibitor 7-Hydroxystaurosporine in Combination With Fluorouracil in Patients With Advanced Solid TumorsJournal of Clinical Oncology, 2005
- Identification of Tyrosine Phosphorylation Sites on 3-Phosphoinositide-dependent Protein Kinase-1 and Their Role in Regulating Kinase ActivityOnline Journal of Public Health Informatics, 2001